News Conference News ISC 2026 CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 06, 2026
News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
News Conference News ISC 2025 Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 11, 2025
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023
News Conference News ISET 2023 The PE Pipeline: Evidence Trickles in for Catheter-Based Therapies Caitlin E. Cox January 23, 2023
News Conference News SCAI 2021 New NACMI COVID-19 Numbers Highlight Quality Care, Sobering Reality Caitlin E. Cox April 28, 2021
News Conference News ISC 2021 Is Tenecteplase Ready for Prime Time in Acute Stroke? Todd Neale March 19, 2021
News Conference News TCT 2020 FlowTriever Looks Good for Acute PE in Interim FLASH Results Todd Neale October 18, 2020
News Conference News ISC 2020 No Need to Go to Higher Tenecteplase Dose for Acute Stroke Todd Neale February 21, 2020
News Conference News STS 2020 PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge Yael L. Maxwell February 03, 2020
News Conference News ACC 2019 No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel Shelley Wood March 19, 2019
News Conference News ISET 2019 Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making Caitlin E. Cox February 05, 2019
News Conference News ACC 2018 TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis Shelley Wood March 11, 2018
News Conference News ISC 2018 More Stroke Thrombectomy Studies Offer Insights Into Subgroups, New Devices, and Lytic Choice Todd Neale January 31, 2018